Home › Funds › Renaissance Technologies › VCEL
Renaissance Technologies position in VCEL
VERICEL CORP · Health Care
Latest position (Q1 2026)12.60K sh
Reported value held$405.34K
Portfolio Weight0.00%
First reportedQ3 2023
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 51.00K | $1.71K | New |
| Q4 2023 | 78.19K | $2.78K | Add |
| Q1 2024 | 134.49K | $7.00K | Add |
| Q2 2024 | 99.80K | $4.58M | Reduce |
| Q3 2024 | 80.30K | $3.39M | Reduce |
| Q4 2024 | 89.50K | $4.91M | Add |
| Q1 2025 | 47.50K | $2.12M | Reduce |
| Q1 2025 | 47.50K | $2.12M | Reduce |
| Q1 2026 | 12.60K | $405.34K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VCEL
- BlackRock Inc 8.09M sh · $360.02M · Q2 2026
- Vanguard Group 3.58M sh · $129.06M · Q4 2025
- Geode Capital Management 1.34M sh · $59.68M · Q2 2026
- Bank of America Corp 1.02M sh · $45.21M · Q2 2026
- Northern Trust Corp 597.64K sh · $26.59M · Q2 2026
- Two Sigma Investments 580.98K sh · $25.85M · Q2 2026
- Goldman Sachs Group 525.62K sh · $23.38M · Q2 2026
- Charles Schwab Investment Management 508.01K sh · $22.60M · Q2 2026
- D. E. Shaw & Co 452.29K sh · $20.12M · Q2 2026
- Point72 Asset Management 443.34K sh · $19.72M · Q2 2026
- Morgan Stanley 404.06K sh · $17.98M · Q2 2026
- UBS Group AG 352.53K sh · $15.68M · Q2 2026